

























![]()
Q1: 2026-05-14 Earnings Summary
EPS of -$0.35 misses by $0.08
|
Revenue of
$19.24M
(4.15% Y/Y)
beats by $600.60K
AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth May 20, 2026 7:00 PM EDT
Company Participants
Cary Vance - President, CEO & Executive Director
David OToole - Chief Financial Officer
Ben Atkins - Vice President of Investor Relations & Corporate Communications
Conference Call Participants
Rudi Michelson
Presentation
Rudi Michelson
Good morning and thank you for joining this AVITA Medical Quarterly Australian Webinar. I'm Rudi Michelson of Monsoon Communications. AVITA CEO, Cary Vance; CFO, David O'Toole; and Ben Atkins, VP, Investor Relations and Corporate Communications, in Australia this week for Brisbane, Sydney, Melbourne roadshow. And this webinar has been arranged, so everyone has the chance to be brief, direct and ask questions on AVITA's progress.
Now let me point out, you can submit questions using the Q&A function, and we'll try and get to them after the presentation.
I'll now hand over to Cary Vance to begin the presentation.
Cary Vance
President, CEO & Executive Director
Thank you, Rudi. It's good to be with you. I appreciate you hosting this event. Let me just start, please, with going back a couple of quarters. I think it's really important to hold the company, myself accountable for what we say each quarter. And that's a culture that's culturally how we run the company and how we expect to communicate externally as well.
In November, after being in the role for a few weeks, I came to Australia and I said, I need to get my hand -- get a handle on the business to really understand it at a deep level, where our opportunities are, where our gaps are so that we can solve those things by the end of the year and really be prepared for growth in 2026.
When I came back in February, I reported back
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。